Treatment Alternatives Not Necessary For Device Patient Labeling - FDA
This article was originally published in The Gray Sheet
Executive Summary
Patient labeling for medical devices will not need to include information about other viable treatment alternatives, as was originally proposed in FDA's March 2000 draft guidance.